Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

Judith A Troughton; Gary Millar; Edward T M Smyth; Lorraine Doherty; Ronan McMullan

doi:10.1093/jac/dkr264

Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

Judith A Troughton
, Gary Millar
, Edward T M Smyth
, Lorraine Doherty
, Ronan McMullan

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and gentamicin) changed, and whether there was any relationship between GNO susceptibility to these antimicrobials and ciprofloxacin usage.

Original language	English
Article number	dkr264
Pages (from-to)	2152-8
Number of pages	7
Journal	Journal of Antimicrobial Chemotherapy
Volume	66
Issue number	9
DOIs	https://doi.org/10.1093/jac/dkr264
Publication status	Published - Sept 2011

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkr264

Cite this

@article{23c230aa0fa3404783ec4fe27d3b4749,

title = "Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics",

abstract = "A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and gentamicin) changed, and whether there was any relationship between GNO susceptibility to these antimicrobials and ciprofloxacin usage.",

author = "Troughton, \{Judith A\} and Gary Millar and Smyth, \{Edward T M\} and Lorraine Doherty and Ronan McMullan",

year = "2011",

month = sep,

doi = "10.1093/jac/dkr264",

language = "English",

volume = "66",

pages = "2152--8",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "1460-2091",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

AU - Troughton, Judith A

AU - Millar, Gary

AU - Smyth, Edward T M

AU - Doherty, Lorraine

AU - McMullan, Ronan

PY - 2011/9

Y1 - 2011/9

N2 - A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and gentamicin) changed, and whether there was any relationship between GNO susceptibility to these antimicrobials and ciprofloxacin usage.

AB - A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and gentamicin) changed, and whether there was any relationship between GNO susceptibility to these antimicrobials and ciprofloxacin usage.

U2 - 10.1093/jac/dkr264

DO - 10.1093/jac/dkr264

M3 - Article

C2 - 21700624

SN - 1460-2091

VL - 66

SP - 2152

EP - 2158

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 9

M1 - dkr264

ER -

Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this